BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2505539)

  • 1. Gd-DTPA-enhanced MR imaging of pituitary adenomas.
    Newton DR; Dillon WP; Norman D; Newton TH; Wilson CB
    AJNR Am J Neuroradiol; 1989; 10(5):949-54. PubMed ID: 2505539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
    Dwyer AJ; Frank JA; Doppman JL; Oldfield EH; Hickey AM; Cutler GB; Loriaux DL; Schiable TF
    Radiology; 1987 May; 163(2):421-6. PubMed ID: 3562821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.
    Davis PC; Hoffman JC; Malko JA; Tindall GT; Takei Y; Avruch L; Braun IF
    AJNR Am J Neuroradiol; 1987; 8(5):817-23. PubMed ID: 3118674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland.
    Doppman JL; Frank JA; Dwyer AJ; Oldfield EH; Miller DL; Nieman LK; Chrousos GP; Cutler GB; Loriaux DL
    J Comput Assist Tomogr; 1988; 12(5):728-35. PubMed ID: 3170830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
    Steiner E; Wimberger D; Imhof H; Knosp E; Hajek P
    Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary microadenoma. MR appearance and correlation with CT.
    Wu W; Thuomas KA
    Acta Radiol; 1995 Sep; 36(5):529-35. PubMed ID: 7640099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.
    Steiner E; Imhof H; Knosp E
    Radiographics; 1989 Jul; 9(4):587-98. PubMed ID: 2756189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRI.
    Boleaga B; Fanghänel G; Cortinas L; Valdés E; Vargas E; Velasco F
    Rev Invest Clin; 1993; 45(1):37-42. PubMed ID: 8387223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa.
    Hamon-Kérautret M; Leclerc X; Dewailly D; Pruvo JP; Fossati P; Clarisse J
    Eur J Radiol; 1994 Aug; 18(3):185-90. PubMed ID: 7957288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR of corticotropin-secreting pituitary microadenomas.
    Colombo N; Loli P; Vignati F; Scialfa G
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1591-5. PubMed ID: 7985584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
    Lundin P; Edén Engström B; Karlsson FA; Burman P
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):765-72. PubMed ID: 9127047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
    Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
    Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary microadenomas. Does Gadolinium enhance their demonstration?
    Macpherson P; Hadley DM; Teasdale E; Teasdale G
    Neuroradiology; 1989; 31(4):293-8. PubMed ID: 2677826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of pituitary adenomas in acromegaly.
    Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
    Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
    Lundin P; Bergström K
    Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
    Nakamura T; Schörner W; Bittner RC; Felix R
    Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: correlation with pituitary anatomy.
    van Nesselrooij JH; Szeverenyi NM; Tillapaugh-Fay GM; Hendriksen FG
    Magn Reson Imaging; 1990; 8(5):525-33. PubMed ID: 2082122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
    Davis PC; Gokhale KA; Joseph GJ; Peterman SB; Adams DA; Tindall GT; Hudgins PA; Hoffman JC
    Radiology; 1991 Sep; 180(3):779-84. PubMed ID: 1871293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
    Finelli DA; Kaufman B
    Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.